Next Quarterly Earnings
Wednesday, August 5, 2026
CW 32
After-Hours
In 31 days
Pulmonx
Pulmonx develops and markets innovative, minimally invasive medical devices for the treatment of severe lung diseases like emphysema and COPD. This US-based company offers advanced therapeutic solutions aimed at sustainably improving patients' respiratory function.
All Dates
Earnings history data not available
Company Information
Name
Pulmonx
Country
🇺🇸
More Financial Information